VC partner want public money to back Israeli biotech

Ruti Alon, general partner of Pitango Venture Capital, says the Israeli government will need to invest a significant amount of capital in its biotech industry if the industry intends to achieve its full potential in the field. The industry needs a half billion dollars a year in new investments, says Alon, and that all can't come from venture capitalists alone.

- check out the report from Globes

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.